| Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist ST Buckley, TA Bækdal, A Vegge, SJ Maarbjerg, C Pyke, J Ahnfelt-Rønne, ... Science translational medicine 10 (467), eaar7047, 2018 | 386 | 2018 |
| An ingestible self-orienting system for oral delivery of macromolecules A Abramson, E Caffarel-Salvador, M Khang, D Dellal, D Silverstein, Y Gao, ... Science 363 (6427), 611-615, 2019 | 343 | 2019 |
| Semaglutide lowers body weight in rodents via distributed neural pathways S Gabery, CG Salinas, SJ Paulsen, J Ahnfelt-Rønne, T Alanentalo, ... JCI insight 5 (6), 2020 | 299 | 2020 |
| The receptor for advanced glycation end products (RAGE) and the lung ST Buckley, C Ehrhardt BioMed Research International 2010, 2010 | 289 | 2010 |
| Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations” ST Buckley, KJ Frank, G Fricker, M Brandl European journal of pharmaceutical sciences 50 (1), 8-16, 2013 | 211 | 2013 |
| In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives ST Buckley, SM Fischer, G Fricker, M Brandl European journal of pharmaceutical sciences 45 (3), 235-250, 2012 | 154 | 2012 |
| The role of citric acid in oral peptide and protein formulations: relationship between calcium chelation and proteolysis inhibition SH Welling, F Hubálek, J Jacobsen, DJ Brayden, UL Rahbek, ST Buckley European journal of pharmaceutics and biopharmaceutics 86 (3), 544-551, 2014 | 77 | 2014 |
| Elucidating the mechanism of absorption of fast-acting insulin aspart: the role of niacinamide J Kildegaard, ST Buckley, RH Nielsen, GK Povlsen, T Seested, U Ribel, ... Pharmaceutical research 36, 1-14, 2019 | 75 | 2019 |
| Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors A Abramson, MR Frederiksen, A Vegge, B Jensen, M Poulsen, ... Nature biotechnology 40 (1), 103-109, 2022 | 73 | 2022 |
| Ligand‐independent transforming growth factor‐β type I receptor signalling mediates type I collagen‐induced epithelial–mesenchymal transition L DeMaio, ST Buckley, MS Krishnaveni, P Flodby, M Dubourd, A Banfalvi, ... The Journal of pathology 226 (4), 633-644, 2012 | 66 | 2012 |
| Transport of the fluorescent organic cation 4-(4-(dimethylamino) styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells JJ Salomon, S Endter, G Tachon, F Falson, ST Buckley, C Ehrhardt European journal of pharmaceutics and biopharmaceutics 81 (2), 351-359, 2012 | 57 | 2012 |
| Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells ST Buckley, C Medina, M Kasper, C Ehrhardt American Journal of Physiology-Lung Cellular and Molecular Physiology 300 (4 …, 2011 | 57 | 2011 |
| Differential susceptibility to epithelial-mesenchymal transition (EMT) of alveolar, bronchial and intestinal epithelial cells in vitro and the effect of angiotensin II receptor … ST Buckley, C Medina, C Ehrhardt Cell and tissue research 342 (1), 39-51, 2010 | 54 | 2010 |
| Cytoskeletal re-arrangement in TGF-β1-induced alveolar epithelial-mesenchymal transition studied by atomic force microscopy and high-content analysis ST Buckley, C Medina, AM Davies, C Ehrhardt Nanomedicine: Nanotechnology, Biology and Medicine 8 (3), 355-364, 2012 | 49 | 2012 |
| Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism B Zhou, ST Buckley, V Patel, Y Liu, J Luo, MS Krishnaveni, M Ivan, ... PloS one 7 (6), e38827, 2012 | 48 | 2012 |
| The insulin receptor is expressed and functional in cultured blood-brain barrier endothelial cells but does not mediate insulin entry from blood to brain M Hersom, HC Helms, C Schmalz, TÅ Pedersen, ST Buckley, B Brodin American Journal of Physiology-Endocrinology and Metabolism 315 (4), E531-E542, 2018 | 46 | 2018 |
| Chemically modified peptides and proteins-critical considerations for oral delivery ST Buckley, F Hubálek, UL Rahbek Tissue barriers 4 (2), e1156805, 2016 | 43 | 2016 |
| Interaction with mixed micelles in the intestine attenuates the permeation enhancing potential of alkyl-maltosides K Gradauer, A Nishiumi, K Unrinin, H Higashino, M Kataoka, BL Pedersen, ... Molecular pharmaceutics 12 (7), 2245-2253, 2015 | 39 | 2015 |
| Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development I Loryan, A Reichel, B Feng, C Bundgaard, C Shaffer, C Kalvass, ... Pharmaceutical research 39 (7), 1321-1341, 2022 | 38 | 2022 |
| In silico modelling of permeation enhancement potency in Caco-2 monolayers based on molecular descriptors and random forest SH Welling, LKH Clemmensen, ST Buckley, L Hovgaard, PB Brockhoff, ... European Journal of Pharmaceutics and Biopharmaceutics 94, 152-159, 2015 | 26 | 2015 |
